Editas Medicine (EDIT) Leases (2019 - 2025)
Historic Leases for Editas Medicine (EDIT) over the last 7 years, with Q3 2025 value amounting to $17.6 million.
- Editas Medicine's Leases fell 5078.65% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year decrease of 5078.65%. This contributed to the annual value of $32.6 million for FY2024, which is 334.32% down from last year.
- As of Q3 2025, Editas Medicine's Leases stood at $17.6 million, which was down 5078.65% from $19.0 million recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Leases ranged from a high of $43.6 million in Q4 2022 and a low of $17.6 million during Q3 2025
- In the last 5 years, Editas Medicine's Leases had a median value of $30.3 million in 2021 and averaged $29.5 million.
- Per our database at Business Quant, Editas Medicine's Leases surged by 6844.58% in 2023 and then tumbled by 5078.65% in 2025.
- Quarter analysis of 5 years shows Editas Medicine's Leases stood at $26.2 million in 2021, then skyrocketed by 66.77% to $43.6 million in 2022, then dropped by 22.84% to $33.7 million in 2023, then decreased by 3.34% to $32.6 million in 2024, then plummeted by 45.99% to $17.6 million in 2025.
- Its last three reported values are $17.6 million in Q3 2025, $19.0 million for Q2 2025, and $26.4 million during Q1 2025.